🔥Telegram İfşa

Another rare cancer Data Note from Matthieu Foll 🦋 @matthieufoll.bsky.social and the IARC Rare Cancers Genomics initiative, this time presenting PDTO data. Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms doi.org/10.1093/gigasc…

📢 Last call for the EMBL International PhD Programme 2025 winter recruitment! One week left to apply for our fully funded PhD programme. Interested and want to find out more? Meet our students: embl.org/about/info/emb… Apply here: embl.org/about/info/emb…

We are thrilled to welcome Yuliya Lim as a PhD student in the team, under the supervision of Nicolas Alcala, L. Fernandez-Cuesta, and Matthieu Foll 🦋 @matthieufoll.bsky.social! Yuliya recieved a competitive PhD fellowship from La Ligue contre le cancer and will work on deciphering the mysteries of cancer ecosystem complexity.

Last 2 days to apply for a postdoctoral position in our lab EMBL Barcelona! #organoids #neuroendocrine cells, #gene by #exposome #cancer_models. If you want to help shape a young & dynamic research group -- please apply! please RT! embl.org/jobs/position/…

This is somehow how I imagine that the initial stage of metastasis happens in the tumour niche

It's #NETCancerDay to raise awareness of #neuroendocrinecancer. EASILY MISSED and misdiagnosed until it spreads.Take a minute to learn more and support the #NET and #NEC community. NET Cancer Day SuzanneRLudlow Mark Lewis, MD, FASCO Josh Mailman

Love elephants and conservation genomics? Want to do a postdoc in applied conservation? Please apply, we have extended the deadline until monday the 18th. docs.google.com/forms/d/e/1FAI…

#Chromothripsis leads to the acquisition of multiple genomic aberrations. Simovic-Lorenz & Ernst (DKFZ) discuss mechanistic models of chromothripsis, outline its role in cancer development + tumour evolution & suggest therapeutic vulnerabilities. 📖👇 bit.ly/4fy8pFo

Would you prefer to lead a lab alone or together with a science buddy? How interesting would be a research institute where joint labs are the standard?!

Honored to speak in this IARC ESMO - Eur. Oncology webinar, where I’ll share the latest evidence on "#Quitting #Smoking After a #Cancer Diagnosis: Key to Better #Survival and #Treatment Outcomes." Details & registration 👇: 🔗 learning.iarc.fr/wcr/courses/we…"

New work reveals the impact of anxiety & depression on PhD students. "Anxiety and depression can have a substantially detrimental impact on graduate students’ experiences [..] and likely also contribute to increased time to degree and student attrition." nature.com/articles/s4158…

🎉 Exciting news! Our paper on kidney cancer is now published! Check it out here: doi.org/10.1038/s44320…

IARC's Dr Michael Olanipekun & Dr Marie-Laure Aix describe the burden of #PancreaticCancer & some of the research being conducted at IARC in this🆕video to mark the close of Pancreatic #Cancer Awareness Month. #DISCERN Aida Ferreiro-Iglesias Paul Brennan Vivian Viallon youtu.be/WXgs0DyNavk

⚡️📣After the success of our previous pathology foundation models UNI (rdcu.be/dBMgh) and CONCH (rdcu.be/dBMf6), we are now announcing TITAN (arxiv.org/abs/2411.19666), a new state-of-the-art whole slide level foundation model trained on >330k pathology slides

Are metastatic #cancers more like their normal origin or target tissues? Our work in Science Advances systematically compares the #transcriptomics of primary and metastatic #tumors to healthy tissues in a #PanCancer, genome-wide manner! #metastasis 🧵1/10 shorturl.at/Uc4xx

#REVIEW 🚨 Kratz highlights the genetics of cancer in children, examining cancer predisposition syndromes + genes, embryonic mosaicisms & polygenic risk scores, focusing on their role in cancer prediction, prevention, surveillance & therapy. Read it 👇 bit.ly/3ZHhZAA

Are you looking forward to 2025 as much as we are? 👀 We just updated our 2025 EMBL Annual Poster to include even more courses and conferences for you to join, so go and have a look! ➡️ s.embl.org/poster-x #EMBLEvents #molecularbiology #lifesciencetraining

Which are the highest cited original research publications in #PancreaticCancer over the past five years (from 2020 to 2024 end)? All metrics obtained from Google Scholar (caveat: GS tends to OVERESTIMATE citations but the trends are consistent overall). 🧵 Below:

The Curtis Lab’s latest study on the genomic architecture of breast cancer from the pre-invasive to metastatic setting is now out in Nature! nature.com/articles/s4158…

Neuroendocrine tumor (NET) incidence has risen over the last 20 years. Fernandez-Cuesta et al. discuss how more rigorous classification of diverse NETs can help ID targetable biological mechanisms in patients with these rare cancers. jci.org/articles/view/…